Stay updated on Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A unified Locations section appears with Illinois and Massachusetts, replacing prior separate location headings. The revision is updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T09:10:25.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision note updated from v3.2.0 to v3.3.2. There are no user-facing changes to the study details.
    Difference
    0.1%
    Check dated 2025-11-24T17:05:38.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The government funding lapse notice and operating-status information (including links to cc.nih.gov and opm.gov) has been removed from the page. This notice previously informed users about potential delays and where to check status updates.
    Difference
    0.4%
    Check dated 2025-11-17T15:04:34.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; core study information (title, purpose, eligibility, endpoints) and the page’s primary functions remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:32:25.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a new medical term; - Updated version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T10:32:53.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Update: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T03:21:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.